首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1410867篇
  免费   99959篇
  国内免费   2319篇
耳鼻咽喉   20507篇
儿科学   46830篇
妇产科学   41159篇
基础医学   206993篇
口腔科学   39163篇
临床医学   118910篇
内科学   275233篇
皮肤病学   30050篇
神经病学   112512篇
特种医学   57034篇
外国民族医学   394篇
外科学   219293篇
综合类   27568篇
现状与发展   1篇
一般理论   349篇
预防医学   99618篇
眼科学   32415篇
药学   107179篇
  5篇
中国医学   2869篇
肿瘤学   75063篇
  2018年   14306篇
  2016年   12792篇
  2015年   14711篇
  2014年   19354篇
  2013年   28927篇
  2012年   40558篇
  2011年   42516篇
  2010年   25159篇
  2009年   23349篇
  2008年   41390篇
  2007年   44951篇
  2006年   45497篇
  2005年   44972篇
  2004年   43205篇
  2003年   42195篇
  2002年   41486篇
  2001年   62510篇
  2000年   64004篇
  1999年   54464篇
  1998年   15443篇
  1997年   13817篇
  1996年   13817篇
  1995年   12971篇
  1994年   12342篇
  1993年   11411篇
  1992年   42724篇
  1991年   42062篇
  1990年   41565篇
  1989年   40230篇
  1988年   37419篇
  1987年   36652篇
  1986年   34932篇
  1985年   33339篇
  1984年   24876篇
  1983年   21547篇
  1982年   12904篇
  1981年   11395篇
  1979年   23648篇
  1978年   16618篇
  1977年   14370篇
  1976年   13524篇
  1975年   15005篇
  1974年   17525篇
  1973年   16866篇
  1972年   16091篇
  1971年   14965篇
  1970年   13873篇
  1969年   13348篇
  1968年   12571篇
  1967年   11027篇
排序方式: 共有10000条查询结果,搜索用时 203 毫秒
181.
182.
Health care expenditure in Germany shows clear regional differences. Such geographic variations are often seen as an indicator for inefficiency. With its homogeneous health care system, low co‐payments and uniform prices, Germany is a particularly suited example to analyse regional variations. We use data for the year 2011 on expenditure, utilization of health services and state of health in Germany's statutory health insurance system. This data, which originate from a variety of administrative sources and cover about 90% of the population, are enriched with a wealth of socio‐economic variables, data on pollutants, prices and individual preferences. State of health and demography explains 55% of the differences as measured by the standard deviation while all control variables account for a total of 72% of the differences at county level. With other measures of variation, we can account for an even greater proportion. A higher proportion of variation than usually supposed can thus be explained. Whilst this study cannot quantify inefficiencies, our results contradict the thesis that regional variations reflect inefficiency. Copyright © 2015 John Wiley & Sons, Ltd.  相似文献   
183.
184.
185.
186.
187.
188.
189.

Background

Physicians treating nonvalvular atrial fibrillation (AF) assess stroke and bleeding risks when deciding on anticoagulation. The agreement between empirical and physician-estimated risks is unclear. Furthermore, the association between patient and physician sex and anticoagulation decision-making is uncertain.

Methods

We pooled data from 2 national primary care physician chart audit databases of patients with AF (Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation and Coordinated National Network to Engage Physicians in the Care and Treatment of Patients with Atrial Fibrillation Chart Audit) with a combined 1035 physicians (133 female, 902 male) and 10,927 patients (4567 female and 6360 male).

Results

Male physicians underestimated stroke risk in female patients and overestimated risk in male patients. Female physicians estimated stroke risk well in female patients but underestimated the risk in male patients. Risk of bleeding was underestimated in all. Despite differences in risk assessment by physician and patient sex, > 90% of patients received anticoagulation across all subgroups. There was modest agreement between physician estimated and calculated (ie, CHADS2 score) stroke risk: Kappa scores were 0.41 (0.35-0.47) for female physicians and 0.34 (0.32-0.36) for male physicians.

Conclusions

Our study is the first to examine the association between patient and physician sex influences and stroke and bleeding risk estimation in AF. Although there were differences in agreement between physician estimated stroke risk and calculated CHADS2 scores, these differences were small and unlikely to affect clinical practice; further, despite any perceived differences in the accuracy of risk assessment by sex, most patients received anticoagulation.  相似文献   
190.

Background

Inflammation and infections have been associated with prostate cancer progression. We assessed whether elevated serum cytokines or T. vaginalis seropositivity at the time of diagnosis was associated with higher grade or lethal prostate cancer.

Patients and Methods

Men with localized or metastatic prostate cancer were included in this study. Cytokine serum levels including interleukin (IL)-1α, IL-1β, IL-2, IL-6, IL-8, monocyte chemotactic protein 1 (CCL-2), tumor necrosis factor α, and growth-regulated oncogene α (CXCL-1) using a multiplex enzyme-linked immunosorbent assay and T. vaginalis serology were measured in blood samples at diagnosis.

Results

A total of 324 patients were identified at time of localized disease and 118 at time of metastatic disease. Of the 189 patients with localized disease and clinical follow-up data (median, 73 months), 28 developed lethal disease. There was no association between circulating cytokine levels above median concentrations nor T. vaginalis seropositivity and risk of intermediate- to high-risk or lethal prostate cancer.

Conclusion

Higher levels of serum cytokine levels and T. vaginalis seropositivity at diagnosis are not associated with high-grade or lethal prostate cancer and do not aid risk stratification of localized prostate cancer.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号